Global and United States mRNA Transcriptome Sequencing Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Software
Publisher : MRA | Format : PDF
Global and United States mRNA Transcriptome Sequencing Market Report & Forecast 2024-2034
In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.
Transcriptome sequencing, or RNA sequencing (RNA-Seq), provides fundamental insights into how genomes are organized and regulated—giving us valuable information about the internal state of cells and how altered expression of genetic variants contributes to complex disease research.
Market Analysis and InsightsGlobal and United States mRNA Transcriptome Sequencing Market
This report focuses on global and United States mRNA Transcriptome Sequencing market, also covers the segmentation data of other regions in regional level and county level.
The global mRNA Transcriptome Sequencing revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the mRNA Transcriptome Sequencing revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of mRNA Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific and Azenta, etc. The global five biggest players hold a share of % in 2023.
Global mRNA Transcriptome Sequencing Scope and Market Size
mRNA Transcriptome Sequencing market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global mRNA Transcriptome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the mRNA Transcriptome Sequencing market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Tech Solutions
Zhijiang Biology
Novogene Co.
Macrogen
Tsingke Biotechnology
Segment by Type
Next Generation Sequencing
Single Molecule Sequencing
Others
Biomedical Field
Non-medical Field
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces mRNA Transcriptome Sequencing definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of mRNA Transcriptome Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of mRNA Transcriptome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Transcriptome Sequencing revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Transcriptome sequencing, or RNA sequencing (RNA-Seq), provides fundamental insights into how genomes are organized and regulated—giving us valuable information about the internal state of cells and how altered expression of genetic variants contributes to complex disease research.
Market Analysis and InsightsGlobal and United States mRNA Transcriptome Sequencing Market
This report focuses on global and United States mRNA Transcriptome Sequencing market, also covers the segmentation data of other regions in regional level and county level.
The global mRNA Transcriptome Sequencing revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2033 with a CAGR of % during the review period (2023-2033).
In United States the mRNA Transcriptome Sequencing revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of mRNA Transcriptome Sequencing include Illumina, Thermo Fisher Scientific, Bio-Rad, Agilent Technologies, QIAGEN, Roche, Pacific Biosciences, Eurofins Scientific and Azenta, etc. The global five biggest players hold a share of % in 2023.
Global mRNA Transcriptome Sequencing Scope and Market Size
mRNA Transcriptome Sequencing market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global mRNA Transcriptome Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the mRNA Transcriptome Sequencing market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Tech Solutions
Zhijiang Biology
Novogene Co.
Macrogen
Tsingke Biotechnology
Segment by Type
Next Generation Sequencing
Single Molecule Sequencing
Others
Segment by Application
Biomedical Field
Non-medical Field
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces mRNA Transcriptome Sequencing definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of mRNA Transcriptome Sequencing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of mRNA Transcriptome Sequencing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Transcriptome Sequencing revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions